The present study was conducted to determine whether there are differences in regional brain TSPO expression, an indication of microglial activation, across schizophrenia illness stages, and is the largest PET study to investigate potential microglial activation in schizophrenia to date. The gene discussed is TSPO; the disease is schizophrenia.